Neuroquímida y Neurodegeneración
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (7)
2014
-
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, Vol. 46, Núm. 9, pp. 989-993
1999
-
Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine- lesioned rats
Neuroscience, Vol. 89, Núm. 3, pp. 781-797
1998
1997
-
125I-galanin binding sites in Alzheimer's disease: Increases in hippocampal subfields and a decrease in the caudate nucleus
Journal of Neurochemistry, Vol. 68, Núm. 3, pp. 1106-1113
-
Biological actions of endogenous excitatory amino acids and implications of their release under physiological and pharmacologically-induced conditions
Amino Acids
-
On the release of glutamate and aspartate in the basal ganglia of the rat: Interactions with monoamines and neuropeptides
Neuroscience and Biobehavioral Reviews, Vol. 21, Núm. 4, pp. 489-495
1996
-
Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: Modulation by the mesencephalic dopamine pathway via D1-subtype of receptor
Neuroscience, Vol. 74, Núm. 1, pp. 51-66